Investigating emerging infectious diseases and developing medical countermeasures.
Pitt RBL
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10910178
This study at the University of Pittsburgh is looking into how germs spread and cause illness, with the goal of creating better treatments and vaccines to help keep everyone safe during outbreaks and health emergencies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10910178 on ClinicalTrials.gov |
What this research studies
The Regional Biocontainment Laboratory at the University of Pittsburgh focuses on understanding how infectious diseases emerge and spread between hosts. This research involves studying the biology of pathogens and their interactions with hosts to develop new medical interventions and countermeasures. Patients may benefit from advancements in treatments and vaccines that arise from this work, particularly in response to pandemics and biological threats. The laboratory collaborates with various disciplines to ensure a comprehensive approach to infection biology.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those involved in healthcare and public health.
Not a fit: Patients with established chronic conditions unrelated to infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for emerging infectious diseases.
How similar studies have performed: Previous research in similar biocontainment settings has shown success in developing vaccines and treatments for infectious diseases.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DUPREX, WILLIAM PAUL — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: DUPREX, WILLIAM PAUL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.